Concepedia

Marcus Bauser

MB

Statistics

Publications

27

Citations

1.6K

H-Index

24

Active since

1998

Affiliations

Bayer (Germany)(Current)

Broad Institute

Janssen (Belgium)

Sprint Bioscience (Sweden)

University of Tübingen

Marcus Bauser is an author at Bayer (Germany) specializing in pharmacology, drug discovery, and medicine.

Publications per year

1998–2023

27

Publications

27

Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY‐876

Hölger Siebeneicher, Arwed Cleve, Hartmut Rehwinkel et al. · ChemMedChem · 2016 · 273 citations · Full text

, , +14

The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies

Sven Christian, Claudia Merz, Laura Evans et al. · Leukemia · 2019 · 246 citations · Full text

, , +17

Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo

Anuhar Chaturvedi, Lena Herbst, Stefan Pusch et al. · Leukemia · 2017 · 119 citations · Full text

, , +10

Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance

Maria Quanz, Eckhard Bender, Charlotte Kopitz et al. · Molecular Cancer Therapeutics · 2018 · 109 citations · Full text

, , +16

New Class of Bacterial Phenylalanyl-tRNA Synthetase Inhibitors with High Potency and Broad-Spectrum Activity

D. Beyer, Hein‐Peter Kroll, Rainer Endermann et al. · Antimicrobial Agents and Chemotherapy · 2004 · 77 citations · Full text

, , +17

1–5 of 27